Om

Cannovum Cannabis AG is a Berlin-based pharmaceutical company focused on medical cannabis products and related services. The company operates as an importer, wholesaler, and manufacturer, serving the healthcare market with cannabis-based medicines and products designed for patient use. Its business also includes medical-scientific education and distribution services that support access to cannabis-based therapies. Cannovum Cannabis AG works within Germany’s regulated cannabis and pharmaceutical environment, where quality control, compliance, and reliable supply are central to its role. The company’s activities connect cultivation, processing, and market distribution, making it a specialized participant in the broader medical cannabis sector. Cannovum Cannabis AG is headquartered in Berlin, Germany.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I CANNOVUM CANNABIS MED ENDAVU: Køb Cannovum Cannabis ($27N0) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Cannovum Cannabis, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.